Filing Details
- Accession Number:
- 0001209191-22-059174
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-01 16:02:39
- Reporting Period:
- 2022-11-29
- Accepted Time:
- 2022-12-01 16:02:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1069308 | Acer Therapeutics Inc. | ACER | Pharmaceutical Preparations (2834) | 320426967 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1717241 | Chris Schelling | C/O Acer Therapeutics Inc. 300 Washington Street., Ste 356 Newton MA 02458 | President & Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-11-29 | 819,672 | $1.22 | 2,712,529 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
